• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Seroprevalence of SARS-CoV-2-Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Aug 26;27(11).
doi: 10.3201/eid2711.204948. Online ahead of print.
Seroprevalence of SARS-CoV-2-Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020

Maria Skaalum Petersen, Marnar Fríðheim Kristiansen, Halla Weihe Reinert, Jógvan Páll Fjallsbak, Debes Hammershaimb Christiansen, Shahin Gaini, Bjarni Á Steig, Lars Fodgaard Møller, Marin Strøm, Pál Weihe

Abstract

Close contacts of coronavirus disease (COVID-19) patients are at high risk for severe acute respiratory syndrome 2 (SARS-CoV-2) infection. We assessed the seroprevalence of SARS-CoV-2-specific antibodies among quarantined close contacts of COVID-19 patients in the Faroe Islands. We invited quarantined close contacts of COVID-19 index patients identified during March 3-April 22, 2020, to participate in this study; 584 (81%) contacts consented and underwent serologic testing. Among the 584 participants, 32 (5.5%) were seropositive for total antibody against SARS-CoV-2. Household and young or elderly contacts had higher risk for seropositivity than other contacts. We found a secondary attack rate of 19.2%. Seroprevalence among close contacts was almost 10-fold higher than among the general population of the Faroe Islands. Regularly testing household close contacts of COVID-19 patients might help track the transmission of SARS-CoV-2.

Keywords: 2019 novel coronavirus disease; COVID-19; Faroe Islands; SARS-CoV-2; SARS-CoV-2 seroprevalence; antibodies; close contacts; coronavirus disease; coronaviruses; quarantine; respiratory infections; secondary attack rate; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom